Cargando…
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
SIMPLE SUMMARY: Cholangiocarcinoma is the second most frequent primary liver tumor in humans. In this review, we report current findings on the mechanisms linking well-known risk factors to this cancer. These pathways may be in part involved in risk factors unrelated to cholangiocarcinoma forms. ABS...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945938/ https://www.ncbi.nlm.nih.gov/pubmed/35326593 http://dx.doi.org/10.3390/cancers14061442 |
_version_ | 1784674073633095680 |
---|---|
author | Ceci, Ludovica Zhou, Tianhao Lenci, Ilaria Meadows, Vik Kennedy, Lindsey Li, Ping Ekser, Burcin Milana, Martina Zhang, Wenjun Wu, Chaodong Sato, Keisaku Chakraborty, Sanjukta Glaser, Shannon S. Francis, Heather Alpini, Gianfranco Baiocchi, Leonardo |
author_facet | Ceci, Ludovica Zhou, Tianhao Lenci, Ilaria Meadows, Vik Kennedy, Lindsey Li, Ping Ekser, Burcin Milana, Martina Zhang, Wenjun Wu, Chaodong Sato, Keisaku Chakraborty, Sanjukta Glaser, Shannon S. Francis, Heather Alpini, Gianfranco Baiocchi, Leonardo |
author_sort | Ceci, Ludovica |
collection | PubMed |
description | SIMPLE SUMMARY: Cholangiocarcinoma is the second most frequent primary liver tumor in humans. In this review, we report current findings on the mechanisms linking well-known risk factors to this cancer. These pathways may be in part involved in risk factors unrelated to cholangiocarcinoma forms. ABSTRACT: The poor prognosis of cholangiocarcinoma in humans is related to several factors, such as (i) the heterogeneity of the disease, (ii) the late onset of symptoms and (iii) the limited comprehension of the carcinogenic pathways determining neoplastic changes, which all limit the pursuit of appropriate treatment. Several risk factors have been recognized, including different infective, immune-mediated, and dysmorphogenic disorders of the biliary tree. In this review, we report the details of possible mechanisms that lead a specific premalignant pathological condition to become cholangiocarcinoma. For instance, during liver fluke infection, factors secreted from the worms may play a major role in pathogenesis. In primary sclerosing cholangitis, deregulation of histamine and bile-acid signaling may determine important changes in cellular pathways. The study of these molecular events may also shed some light on the pathogenesis of sporadic (unrelated to risk factors) forms of cholangiocarcinoma, which represent the majority (nearly 75%) of cases. |
format | Online Article Text |
id | pubmed-8945938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89459382022-03-25 Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development Ceci, Ludovica Zhou, Tianhao Lenci, Ilaria Meadows, Vik Kennedy, Lindsey Li, Ping Ekser, Burcin Milana, Martina Zhang, Wenjun Wu, Chaodong Sato, Keisaku Chakraborty, Sanjukta Glaser, Shannon S. Francis, Heather Alpini, Gianfranco Baiocchi, Leonardo Cancers (Basel) Review SIMPLE SUMMARY: Cholangiocarcinoma is the second most frequent primary liver tumor in humans. In this review, we report current findings on the mechanisms linking well-known risk factors to this cancer. These pathways may be in part involved in risk factors unrelated to cholangiocarcinoma forms. ABSTRACT: The poor prognosis of cholangiocarcinoma in humans is related to several factors, such as (i) the heterogeneity of the disease, (ii) the late onset of symptoms and (iii) the limited comprehension of the carcinogenic pathways determining neoplastic changes, which all limit the pursuit of appropriate treatment. Several risk factors have been recognized, including different infective, immune-mediated, and dysmorphogenic disorders of the biliary tree. In this review, we report the details of possible mechanisms that lead a specific premalignant pathological condition to become cholangiocarcinoma. For instance, during liver fluke infection, factors secreted from the worms may play a major role in pathogenesis. In primary sclerosing cholangitis, deregulation of histamine and bile-acid signaling may determine important changes in cellular pathways. The study of these molecular events may also shed some light on the pathogenesis of sporadic (unrelated to risk factors) forms of cholangiocarcinoma, which represent the majority (nearly 75%) of cases. MDPI 2022-03-11 /pmc/articles/PMC8945938/ /pubmed/35326593 http://dx.doi.org/10.3390/cancers14061442 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ceci, Ludovica Zhou, Tianhao Lenci, Ilaria Meadows, Vik Kennedy, Lindsey Li, Ping Ekser, Burcin Milana, Martina Zhang, Wenjun Wu, Chaodong Sato, Keisaku Chakraborty, Sanjukta Glaser, Shannon S. Francis, Heather Alpini, Gianfranco Baiocchi, Leonardo Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development |
title | Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development |
title_full | Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development |
title_fullStr | Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development |
title_full_unstemmed | Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development |
title_short | Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development |
title_sort | molecular mechanisms linking risk factors to cholangiocarcinoma development |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945938/ https://www.ncbi.nlm.nih.gov/pubmed/35326593 http://dx.doi.org/10.3390/cancers14061442 |
work_keys_str_mv | AT ceciludovica molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT zhoutianhao molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT lenciilaria molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT meadowsvik molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT kennedylindsey molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT liping molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT ekserburcin molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT milanamartina molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT zhangwenjun molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT wuchaodong molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT satokeisaku molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT chakrabortysanjukta molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT glasershannons molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT francisheather molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT alpinigianfranco molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment AT baiocchileonardo molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment |